{"id":"https://openalex.org/W7225564384","doi":"https://doi.org/10.5281/zenodo.24056865","title":"FORMULATION AND OPTIMIZATION OF GEMIFLOXACIN-LOADED TRANSDERMAL PATCHES FOR ENHANCED SYSTEMIC BIOAVAILABILITY","display_name":"FORMULATION AND OPTIMIZATION OF GEMIFLOXACIN-LOADED TRANSDERMAL PATCHES FOR ENHANCED SYSTEMIC BIOAVAILABILITY","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225564384","doi":"https://doi.org/10.5281/zenodo.24056865"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24056865","doi":"https://doi.org/10.5281/zenodo.24056865","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056865","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24056865","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161270252","display_name":"Rathlavath Priyanka, I.Nagaraju, K Kishore, G Vijaya Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rathlavath Priyanka, I.Nagaraju, K Kishore, G Vijaya Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5161270252"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemifloxacin","display_name":"gemifloxacin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.9259999990463257},{"id":"https://openalex.org/keywords/matrix-type-transdermal-drug-delivery","display_name":"matrix-type transdermal drug delivery","score":0.8659999966621399},{"id":"https://openalex.org/keywords/eudragit-l100","display_name":"Eudragit L100","score":0.9330000281333923},{"id":"https://openalex.org/keywords/eudragit-s100","display_name":"Eudragit S100","score":0.9750000238418579},{"id":"https://openalex.org/keywords/eudragit-rspo","display_name":"Eudragit RSPO","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8349999785423279},{"id":"https://openalex.org/keywords/in-vitro-drug-diffusion","display_name":"in vitro drug diffusion","score":0.7570000290870667},{"id":"https://openalex.org/keywords/zero-order-release-kinetics","display_name":"zero-order release kinetics","score":0.843999981880188},{"id":"https://openalex.org/keywords/zeta-potential","display_name":"zeta potential","score":0.7390000224113464},{"id":"https://openalex.org/keywords/systemic-bioavailability","display_name":"systemic bioavailability","score":0.6850000023841858},{"id":"https://openalex.org/keywords/formulation-optimization","display_name":"formulation optimization","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.8672999739646912},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6875},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.656000018119812},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5597000122070312},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.5515999794006348},{"id":"https://openalex.org/C2777937549","wikidata":"https://www.wikidata.org/wiki/Q5464303","display_name":"Folding endurance","level":4,"score":0.5289999842643738},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.515500009059906},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4973999857902527},{"id":"https://openalex.org/C2776088887","wikidata":"https://www.wikidata.org/wiki/Q1639595","display_name":"Gemifloxacin","level":4,"score":0.4645000100135803},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.44699999690055847},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4449999928474426},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.42559999227523804},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3878999948501587},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.36730000376701355},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C23531484","wikidata":"https://www.wikidata.org/wiki/Q3196863","display_name":"Calibration curve","level":3,"score":0.350600004196167},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.3393999934196472},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.33169999718666077},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.3296999931335449},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.26919999718666077},{"id":"https://openalex.org/C160892712","wikidata":"https://www.wikidata.org/wiki/Q901559","display_name":"Fourier transform infrared spectroscopy","level":2,"score":0.262800008058548},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.2542000114917755}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24056865","doi":"https://doi.org/10.5281/zenodo.24056865","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056865","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.5281/zenodo.24056866","doi":"https://doi.org/10.5281/zenodo.24056866","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056866","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24056865","doi":"https://doi.org/10.5281/zenodo.24056865","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056865","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7115167424","https://openalex.org/W2255896218","https://openalex.org/W7219314024","https://openalex.org/W7160555914","https://openalex.org/W4412897977","https://openalex.org/W3216042770","https://openalex.org/W4289106815","https://openalex.org/W7154451909","https://openalex.org/W2157820556","https://openalex.org/W7170827099"],"abstract_inverted_index":{"This":[0],"study":[1,181],"aimed":[2],"to":[3,12,72],"formulate":[4],"and":[5,15,35,47,85,103,148,160,199],"evaluate":[6],"matrix-type":[7,188],"transdermal":[8,68,189],"patches":[9,90,190],"of":[10,30,79,108,153,186,195],"Gemifloxacin":[11,31,198],"achieve":[13],"sustained":[14],"effective":[16,193],"drug":[17,53,105,120,146,166,201],"delivery.":[18,202],"Preformulation":[19],"studies,":[20],"including":[21,96],"UV-visible":[22],"spectroscopy,":[23],"established":[24],"the":[25,51,57,136,154,171,175,180,184,192],"maximum":[26],"absorption":[27],"wavelength":[28],"()":[29],"at":[32],"271":[33],"nm,":[34],"a":[36,161],"standard":[37],"calibration":[38],"curve":[39],"was":[40],"successfully":[41,139,182],"constructed.":[42],"Compatibility":[43],"studies":[44,117],"using":[45,76],"FTIR":[46],"DSC":[48],"confirmed":[49],"that":[50,119,170],"pure":[52],"is":[54,122],"compatible":[55],"with":[56,132,144],"selected":[58],"polymers,":[59],"showing":[60],"no":[61],"unexpected":[62],"chemical":[63],"interactions":[64],"or":[65],"degradation.":[66],"Nine":[67],"patch":[69,173],"formulations":[70],"(F1":[71],"F9)":[73],"were":[74,91],"prepared":[75,89],"varying":[77],"concentrations":[78],"polymers":[80],"such":[81],"as":[82,135],"Eudragit-L100,":[83],"Eudragit-S100,":[84],"Eudragit":[86],"RSPO.":[87],"The":[88],"evaluated":[92],"for":[93,191],"physicochemical":[94],"parameters":[95,143],"weight":[97],"variation,":[98],"thickness,":[99],"folding":[100],"endurance,":[101],"flatness,":[102],"percentage":[104],"content,":[106],"all":[107,128,141],"which":[109],"met":[110],"acceptable":[111],"pharmacopeial":[112],"standards.":[113],"In":[114],"vitro":[115],"diffusion":[116],"demonstrated":[118],"release":[121,167,177],"dependent":[123],"on":[124],"polymer":[125],"concentration.":[126],"Among":[127],"formulations,":[129],"F3":[130,155],"(formulated":[131],"Eudragit-L100)":[133],"emerged":[134],"optimized":[137,172],"formulation,":[138],"passing":[140],"evaluation":[142],"optimal":[145],"permeation":[147],"stability.":[149],"Zeta":[150],"potential":[151],"analysis":[152],"formulation":[156],"indicated":[157],"good":[158],"stability":[159],"smooth":[162],"surface":[163],"character.":[164],"Furthermore,":[165],"kinetics":[168],"revealed":[169],"followed":[174],"zero-order":[176],"model.":[178],"Overall,":[179],"demonstrates":[183],"viability":[185],"Eudragit-L100":[187],"delivery":[194],"Gemifloxacin.":[196],"Keywords:":[197],"Transdermal":[200]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}